$BGFV
BIG 5 SPORTING GOODS Corp

2024 Q2 Form 10-Q Financial Statement

#000095017024051062 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $199.8M $193.4M
YoY Change -11.17% -18.83%
Cost Of Revenue $141.1M $133.0M
YoY Change -5.8% -16.06%
Gross Profit $58.72M $60.40M
YoY Change -21.85% -24.34%
Gross Profit Margin 29.39% 31.23%
Selling, General & Admin $72.23M $71.38M
YoY Change -3.92% -7.96%
% of Gross Profit 122.99% 118.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.809M $4.558M
YoY Change 3.98% -3.27%
% of Gross Profit 8.19% 7.55%
Operating Expenses $72.23M $71.38M
YoY Change -3.92% -7.96%
Operating Profit -$13.50M -$10.98M
YoY Change 46462.07% -580.99%
Interest Expense -$82.00K -$123.0K
YoY Change -171.3% -32.79%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$13.59M -$11.10M
YoY Change -15896.51% -628.76%
Income Tax -$3.581M -$2.818M
% Of Pretax Income
Net Earnings -$10.00M -$8.286M
YoY Change -5283.42% -579.51%
Net Earnings / Revenue -5.01% -4.28%
Basic Earnings Per Share -$0.46 -$0.38
Diluted Earnings Per Share -$0.46 -$0.38
COMMON SHARES
Basic Shares Outstanding 22.62M 22.44M
Diluted Shares Outstanding 21.96M 21.83M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.938M $12.62M
YoY Change -82.02% -50.63%
Cash & Equivalents $4.938M $12.62M
Short-Term Investments
Other Short-Term Assets $13.85M $12.63M
YoY Change -8.41% -24.06%
Inventory $289.6M $275.8M
Prepaid Expenses $13.85M $12.63M
Receivables $10.45M $8.778M
Other Receivables $0.00 $0.00
Total Short-Term Assets $318.8M $309.9M
YoY Change -13.65% -13.43%
LONG-TERM ASSETS
Property, Plant & Equipment $56.79M $314.7M
YoY Change 1.92% 439.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.428M $16.20M
YoY Change 17.96% 148.6%
Total Long-Term Assets $350.6M $339.7M
YoY Change 2.32% -3.18%
TOTAL ASSETS
Total Short-Term Assets $318.8M $309.9M
Total Long-Term Assets $350.6M $339.7M
Total Assets $669.4M $649.6M
YoY Change -5.97% -8.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $92.00M $69.82M
YoY Change -0.48% 3.56%
Accrued Expenses $59.32M $125.1M
YoY Change -2.64% 78.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.712M $3.984M
YoY Change 28.84% 23.84%
Total Short-Term Liabilities $221.0M $198.9M
YoY Change -1.83% -5.94%
LONG-TERM LIABILITIES
Long-Term Debt $10.37M $11.29M
YoY Change 56.28% 59.3%
Other Long-Term Liabilities $6.061M $203.9M
YoY Change -14.71% 2873.85%
Total Long-Term Liabilities $6.061M $215.2M
YoY Change -14.71% 3038.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $221.0M $198.9M
Total Long-Term Liabilities $6.061M $215.2M
Total Liabilities $444.3M $414.1M
YoY Change -0.88% -5.88%
SHAREHOLDERS EQUITY
Retained Earnings $149.1M $160.3M
YoY Change -21.88% -18.34%
Common Stock $130.1M $129.4M
YoY Change 2.57% 2.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $54.26M $54.26M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $225.0M $235.4M
YoY Change
Total Liabilities & Shareholders Equity $669.4M $649.6M
YoY Change -5.97% -8.36%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$10.00M -$8.286M
YoY Change -5283.42% -579.51%
Depreciation, Depletion And Amortization $4.809M $4.558M
YoY Change 3.98% -3.27%
Cash From Operating Activities -$11.14M $8.213M
YoY Change -190.63% 455.68%
INVESTING ACTIVITIES
Capital Expenditures $4.456M $1.810M
YoY Change 76.2% -58.54%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.456M -$1.810M
YoY Change 76.2% -58.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.913M -2.983M
YoY Change -200.56% -50.17%
NET CHANGE
Cash From Operating Activities -11.14M 8.213M
Cash From Investing Activities -4.456M -1.810M
Cash From Financing Activities 7.913M -2.983M
Net Change In Cash -7.683M 3.420M
YoY Change -505.65% -138.54%
FREE CASH FLOW
Cash From Operating Activities -$11.14M $8.213M
Capital Expenditures $4.456M $1.810M
Free Cash Flow -$15.60M $6.403M
YoY Change -259.75% -321.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001156388
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-49850
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
BIG 5 SPORTING GOODS CORPORATION
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4388794
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2525 East El Segundo Boulevard
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
El Segundo
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90245
CY2024Q1 dei City Area Code
CityAreaCode
310
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
536-0611
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
BGFV
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22624232
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12621000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9201000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
63000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
48000
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
8778000
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9163000
CY2024Q1 us-gaap Inventory Net
InventoryNet
275839000
CY2023Q4 us-gaap Inventory Net
InventoryNet
275759000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12631000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16052000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
309869000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
310175000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
258014000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
253615000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56653000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58595000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16196000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13427000
CY2024Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
2137000
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1954000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8828000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8871000
CY2024Q1 us-gaap Assets
Assets
649560000
CY2023Q4 us-gaap Assets
Assets
644683000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
69818000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
55201000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57306000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61283000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67805000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70372000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3984000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3843000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
198913000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
190699000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
197612000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191178000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11293000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11856000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6305000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6536000
CY2024Q1 us-gaap Liabilities
Liabilities
414123000
CY2023Q4 us-gaap Liabilities
Liabilities
400269000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26932297
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26747617
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22625042
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22440362
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
269000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
267000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
129150000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
128737000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
160275000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
169667000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4307255
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4307255
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
54257000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
54257000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
235437000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
244414000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
649560000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
644683000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193427000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
224939000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
133029000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
149795000
CY2024Q1 us-gaap Gross Profit
GrossProfit
60398000
CY2023Q2 us-gaap Gross Profit
GrossProfit
75144000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71379000
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1036000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80000
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11922000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3281000
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-771000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75173000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10981000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29000
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-123000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
115000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11104000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
86000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2818000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-107000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8286000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
193000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21832000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21629000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21832000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21949000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
244414000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8286000
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1106000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
718000
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
308000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
235437000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
268784000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
193000
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5540000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
57000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
679000
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
619000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
263554000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8286000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
193000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4375000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4510000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
718000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
679000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
183000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
115000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17353000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17451000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2769000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-107000
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-385000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14612000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25364000
CY2024Q1 bgfv Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-17885000
CY2023Q2 bgfv Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-17970000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3674000
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7828000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8213000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12292000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1810000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2529000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1810000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2529000
CY2024Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-86000
CY2023Q2 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-383000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
899000
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
818000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
57000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
308000
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
619000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1695000
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6106000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2983000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7869000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3420000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1894000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9201000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25565000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12621000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27459000
CY2024Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
477000
CY2023Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
30000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
857000
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
946000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
303000
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
154000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
12000
CY2024Q1 us-gaap Number Of Stores
NumberOfStores
424
CY2024Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
12000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reporting Period</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company follows the concept of a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">52</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> week fiscal year, which ends on the Sunday nearest December 31. Fiscal year </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024 is comprised of 52 weeks and ends on December 29, 2024. Fiscal year 2023 was comprised of 52 weeks and ended on December 31, 2023. The interim periods in fiscal 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> are each comprised of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> weeks.</span></p>
CY2024Q1 bgfv Financial Information Reporting Period Minimum
FinancialInformationReportingPeriodMinimum
P364D
CY2024Q1 bgfv Financial Information Reporting Period Maximum
FinancialInformationReportingPeriodMaximum
P371D
CY2024Q1 bgfv Financial Information Interim Reporting Period Maximum
FinancialInformationInterimReportingPeriodMaximum
P91D
CY2023Q2 bgfv Financial Information Interim Reporting Period Maximum
FinancialInformationInterimReportingPeriodMaximum
P91D
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">General Concentration of Risk</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company purchases merchandise from over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">600</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> suppliers, and the Company’s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> largest suppliers accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">39.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of total purchases in fiscal 2023. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">One</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> vendor represented greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of total purchases in fiscal 2023, at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A substantial amount of the Company’s inventory is manufactured abroad and, from time to time, shipping ports may experience capacity constraints (such as delays associated with the novel coronavirus “COVID-19”), labor strikes, work stoppages or other disruptions that may delay the delivery of imported products. A contract dispute may lead to protracted delays in the movement of the Company’s products, which could further delay the delivery of products to the Company’s stores and impact net sales and profitability. In addition, other conditions outside of the Company’s control, such as adverse weather conditions or acts of terrorism or war, such as the current conflicts in Ukraine and the Middle East, could significantly disrupt operations at shipping ports or otherwise impact transportation of the imported merchandise we sell, either through supply chain disruptions, or rising freight and fuel costs.</span></p>
CY2023 bgfv Concentration Risk Number Of Suppliers
ConcentrationRiskNumberOfSuppliers
600
CY2023 bgfv Concentration Of Risk Number Of Major Customers
ConcentrationOfRiskNumberOfMajorCustomers
20
CY2023Q4 bgfv Concentration Risk Percentage Of Purchases
ConcentrationRiskPercentageOfPurchases
0.393
CY2023Q4 bgfv Concentration Risk Number Of Customers That Accounted For Greater Than Five Percent Of Purchases
ConcentrationRiskNumberOfCustomersThatAccountedForGreaterThanFivePercentOfPurchases
1
CY2023 bgfv Concentration Of Risk Percentage Of Purchases Threshold
ConcentrationOfRiskPercentageOfPurchasesThreshold
0.05
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Management makes a number of estimates and assumptions relating to the reporting of assets, liabilities and stockholders’ equity and the disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and reported amounts of revenue and expense during the reporting period to prepare these Interim Financial Statements in conformity with GAAP. Certain items subject to such estimates and assumptions include the carrying amount of merchandise inventories, property and equipment, lease assets and lease liabilities; valuation allowances for receivables, sales returns and deferred income tax assets; estimates related to stored-value cards and the valuation of share-based compensation awards; and obligations related to litigation, self-insurance liabilities and employee benefits. Due to the inherent uncertainty involved in making assumptions and estimates, events and changes in circumstances arising after March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> may result in actual outcomes that differ from those contemplated by management’s assumptions and estimates.</span></p>
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193427000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
224939000
CY2024Q1 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one
CY2023Q2 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one
CY2024Q1 bgfv Stored Value Card Redemption Revenue Recognized
StoredValueCardRedemptionRevenueRecognized
1400000
CY2023Q2 bgfv Stored Value Card Redemption Revenue Recognized
StoredValueCardRedemptionRevenueRecognized
1700000
CY2024Q1 bgfv Stored Value Card Liabilities
StoredValueCardLiabilities
8700000
CY2023Q4 bgfv Stored Value Card Liabilities
StoredValueCardLiabilities
9200000
CY2024Q1 bgfv Revenue Recognition Gift Cards Redemption Period
RevenueRecognitionGiftCardsRedemptionPeriod
P2Y
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2024Q1 bgfv Long Lived Assets Subject To Impairment
LongLivedAssetsSubjectToImpairment
0
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
253600000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58600000
CY2023Q4 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
600000
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
600000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21355000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22331000
CY2024Q1 bgfv Accrued Occupancy Costs Current
AccruedOccupancyCostsCurrent
8803000
CY2023Q4 bgfv Accrued Occupancy Costs Current
AccruedOccupancyCostsCurrent
8655000
CY2024Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6234000
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7581000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20914000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22716000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57306000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61283000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
21039000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
21038000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
4682000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
4813000
CY2024Q1 bgfv Operating Lease Cost Including Variable Lease
OperatingLeaseCostIncludingVariableLease
25721000
CY2023Q2 bgfv Operating Lease Cost Including Variable Lease
OperatingLeaseCostIncludingVariableLease
25851000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1142000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
950000
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
228000
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
79000
CY2024Q1 bgfv Finance Lease Expense
FinanceLeaseExpense
1370000
CY2023Q2 bgfv Finance Lease Expense
FinanceLeaseExpense
1029000
CY2024Q1 us-gaap Lease Cost
LeaseCost
27091000
CY2023Q2 us-gaap Lease Cost
LeaseCost
26880000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
22213000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
22211000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
899000
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
818000
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
261000
CY2023Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
85000
CY2024Q1 bgfv Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
23373000
CY2023Q2 bgfv Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
23114000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
517000
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
30000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21674000
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11183000
CY2024Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.062
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.039
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
3749000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
61091000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
4372000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
72583000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
4057000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
56475000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
2824000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
39897000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
4620000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
28472000
CY2024Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
594000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
45683000
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
20216000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
304201000
CY2024Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.062
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
15277000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
265417000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3984000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67805000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11293000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
197612000
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
15277000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
265417000
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4939000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
38784000
CY2024Q1 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
The Company, Big 5 Corp. and Big 5 Services Corp. are parties to a Loan, Guaranty and Security Agreement with Bank of America, N.A. (“BofA”), as agent and lender, which was amended on November 22, 2021, October 19, 2022 and May 16, 2023 (as so amended, the “Loan Agreement”).
CY2024Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2000000
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2000000
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2024Q1 bgfv Unrecognized Tax Benefits Period That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsPeriodThatWouldImpactEffectiveTaxRate
over the next 12 months
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8286000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
193000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21832000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21629000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
320000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21832000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21949000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 bgfv Number Of Stores Destroyed In Roof Collapse
NumberOfStoresDestroyedInRoofCollapse
1
CY2023Q1 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
400000
CY2023Q4 bgfv Loss Contingency Receivable Deduction
LossContingencyReceivableDeduction
500000
CY2023Q4 bgfv Proceeds From Insurance Recoveries Net
ProceedsFromInsuranceRecoveriesNet
700000
CY2023Q4 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
600000
CY2023Q4 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
100000
CY2023Q4 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
300000
CY2023Q4 bgfv Gain On Property Insurance Recoveries Associated With Property Plant And Equipment
GainOnPropertyInsuranceRecoveriesAssociatedWithPropertyPlantAndEquipment
25000
CY2024Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
0
CY2023Q3 bgfv Cumulative Indemnity Reserve On Tentative Settlement
CumulativeIndemnityReserveOnTentativeSettlement
1500000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
253385
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.47
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
272000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.8
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2425
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.23
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
522960
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.65
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
177731000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
238460
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.79
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M10D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
177731000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
517569
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.65
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y8M23D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
177731000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y6M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.776
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.041
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
86005
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
300000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000950170-24-051062-index-headers.html Edgar Link pending
0000950170-24-051062-index.html Edgar Link pending
0000950170-24-051062.txt Edgar Link pending
0000950170-24-051062-xbrl.zip Edgar Link pending
bgfv-20240331.htm Edgar Link pending
bgfv-20240331.xsd Edgar Link pending
bgfv-ex15_1.htm Edgar Link pending
bgfv-ex31_1.htm Edgar Link pending
bgfv-ex31_2.htm Edgar Link pending
bgfv-20240331_htm.xml Edgar Link completed
bgfv-ex32_1.htm Edgar Link pending
bgfv-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable